Clinical Psychedelic Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical psychedelic lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Psychedelic Lab Today - Breaking & Trending Today

Exploring the Future of Psychedelic Therapies in Medicine

Psychedelic medicine is a controversial but intriguing area of science that continues to generate interest from the health and medical sector. Could this potential therapy be used to treat one of the deadliest psychiatric disorders, anorexia nervosa? ....

Philip Gerrans , Paul Liknaitzky , Department Of Philosophy , University Of Adelaide Professor Jon Jureidini , University Of Adelaide , Monash Centre For Consciousness , University Of Adelaide Professor Philip Gerrans , Clinical Psychedelic Lab At Monash University , University Of Adelaide Department Philosophy , Psychedelic Psychiatry , Monash Centre , Contemplative Studies , Professor Philip Gerrans , Professor Gerran , Clinical Psychedelic Lab , Monash University , Professor Jon Jureidini ,

Australian Doctors Are Trialling Psilocybin To Treat Anxiety

Australian Dr Paul Liknaitzky and his lab at Clinical Psychedelic Lab, Monash University are leading the charge using psilocybin the active ingredient found in magic mushrooms to treat anxiety. ....

South Australia , Paul Liknaizky , Monash University , National Drug Strategy Household , Clinical Psychedelic Lab At Monash University , Australia Monash University , Therapeutic Goods Administration , Many Aussies , Drug Strategy Household Survey , Clinical Psychedelic Lab , Generalised Anxiety ,

New documentary explores Australia's psychedelic treatments

New documentary explores Australia's psychedelic treatments
abc.net.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc.net.au Daily Mail and Mail on Sunday newspapers.

South Australia , Paul Liknaitzky , Clinical Psychedelic Lab At Monash University , Clinical Psychedelic Lab ,

Incannex Announces Positive Topline Results from Phase 2

Highlights: PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of 12.8. ....

South Australia , United States , Joel Latham , Paul Liknaitzky , Laine Yonker , Edison Group , Clinical Psychedelic Lab At Monash University , Incannex Healthcare Inc , Drug Administration , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Highlights:PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of. ....

South Australia , United States , Laine Yonker , Joel Latham , Paul Liknaitzky , Incannex Healthcare Inc , Edison Group , Drug Administration , Clinical Psychedelic Lab At Monash University , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,